Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference

SALT LAKE CITY, Sept. 30, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that it will present and meet with investors at the H.C. Wainwright 8th Annual MASH Investor Conference, to take place virtually on October 7, 2024. Presentation Details Time: 2:00 to 2:30pm ET Date: Monday, October 7, 2024 Webcast Link: https://journey.ct.events/view/c252f9f3-ea24-4af7 ...